In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir: Prospective Multicenter Randomized Trial Versus Placebo.
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2012
At a glance
- Drugs Valaciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- Acronyms CYMEVAL
- 01 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Feb 2011 Planned end date changed from 1 Oct 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 05 Jan 2010 New trial record